Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Altshuler

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Neuropsychiatry, Neuropsychology, and Behavioral Neurology|November 29, 2001
Relationship between prior course of illness and neuroanatomic structures in bipolar disorder: a preliminary studyS O Ali, K D Denicoff, L L Altshuler, et al.
Molecular Psychiatry|February 23, 2005
Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depressionM Bauer, E D London, N Rasgon, et al.
Acta Psychiatrica Scandinavica|April 14, 2007
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful studyW A Nolen, R W Kupka, G Hellemann, et al.
Bipolar Disorders|March 26, 2002
Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizersR M Post, L L Altshuler, M A Frye, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodologyG S Leverich, W A Nolen, A J Rush, et al.
Bipolar Disorders|March 21, 2001
Gabapentin in the acute treatment of refractory bipolar disorderL L Altshuler, P E Keck, S L McElroy, et al.
The British Journal of Psychiatry. Supplement|July 14, 2001
The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatmentsR W Kupka, W A Nolen, L L Altshuler, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patientsT Suppes, G S Leverich, P E Keck, et al.
Biological Psychiatry|June 23, 2000
Open-label adjunctive topiramate in the treatment of bipolar disordersS L McElroy, T Suppes, P E Keck, et al.
The American Journal of Psychiatry|March 7, 2001
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorderS L McElroy, L L Altshuler, T Suppes, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Neuropsychiatry, Neuropsychology, and Behavioral Neurology|November 29, 2001
Relationship between prior course of illness and neuroanatomic structures in bipolar disorder: a preliminary studyS O Ali, K D Denicoff, L L Altshuler, et al.
Molecular Psychiatry|February 23, 2005
Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depressionM Bauer, E D London, N Rasgon, et al.
Acta Psychiatrica Scandinavica|April 14, 2007
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful studyW A Nolen, R W Kupka, G Hellemann, et al.
Bipolar Disorders|March 26, 2002
Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizersR M Post, L L Altshuler, M A Frye, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodologyG S Leverich, W A Nolen, A J Rush, et al.
Bipolar Disorders|March 21, 2001
Gabapentin in the acute treatment of refractory bipolar disorderL L Altshuler, P E Keck, S L McElroy, et al.
The British Journal of Psychiatry. Supplement|July 14, 2001
The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatmentsR W Kupka, W A Nolen, L L Altshuler, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patientsT Suppes, G S Leverich, P E Keck, et al.
Biological Psychiatry|June 23, 2000
Open-label adjunctive topiramate in the treatment of bipolar disordersS L McElroy, T Suppes, P E Keck, et al.
The American Journal of Psychiatry|March 7, 2001
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorderS L McElroy, L L Altshuler, T Suppes, et al.
Pageof 9